KR102547565B1 - 호염기구 활성화 검사 방법 - Google Patents

호염기구 활성화 검사 방법 Download PDF

Info

Publication number
KR102547565B1
KR102547565B1 KR1020180091151A KR20180091151A KR102547565B1 KR 102547565 B1 KR102547565 B1 KR 102547565B1 KR 1020180091151 A KR1020180091151 A KR 1020180091151A KR 20180091151 A KR20180091151 A KR 20180091151A KR 102547565 B1 KR102547565 B1 KR 102547565B1
Authority
KR
South Korea
Prior art keywords
basophil
basophils
ligand
activated
allergen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020180091151A
Other languages
English (en)
Korean (ko)
Other versions
KR20190016446A (ko
Inventor
그룬 쥴리아
세즈만 헤닝
바이만 앨프
Original Assignee
유로이뮨 메디지니쉐 라보디아그노스티카 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17001352.8A external-priority patent/EP3441763A1/de
Application filed by 유로이뮨 메디지니쉐 라보디아그노스티카 아게 filed Critical 유로이뮨 메디지니쉐 라보디아그노스티카 아게
Publication of KR20190016446A publication Critical patent/KR20190016446A/ko
Application granted granted Critical
Publication of KR102547565B1 publication Critical patent/KR102547565B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ecology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
KR1020180091151A 2017-08-08 2018-08-06 호염기구 활성화 검사 방법 Active KR102547565B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17001352.8 2017-08-08
EP17001352.8A EP3441763A1 (de) 2017-08-08 2017-08-08 Verfahren zum nachweis einer basophilenaktivierung
EP17001979.8 2017-12-05
EP17001979 2017-12-05

Publications (2)

Publication Number Publication Date
KR20190016446A KR20190016446A (ko) 2019-02-18
KR102547565B1 true KR102547565B1 (ko) 2023-06-26

Family

ID=63041937

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180091151A Active KR102547565B1 (ko) 2017-08-08 2018-08-06 호염기구 활성화 검사 방법

Country Status (13)

Country Link
US (1) US11119109B2 (https=)
EP (1) EP3441765B1 (https=)
JP (1) JP7265325B2 (https=)
KR (1) KR102547565B1 (https=)
CN (1) CN109387636B (https=)
AU (1) AU2018213977B2 (https=)
BR (1) BR102018015288A2 (https=)
CA (1) CA3012989C (https=)
DE (1) DE102018006212A1 (https=)
ES (1) ES2904354T3 (https=)
LT (1) LT3441765T (https=)
PL (1) PL3441765T3 (https=)
SG (1) SG10201806697RA (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210382070A1 (en) * 2020-06-04 2021-12-09 The Chinese University Of Hong Kong Diagnostic biomarkers for shrimp allergy
CN112630423A (zh) * 2020-12-31 2021-04-09 杭州福德敏生物技术有限公司 一种小麦免疫荧光检测试纸条及应用
KR102497904B1 (ko) * 2021-02-10 2023-02-10 재단법인 아산사회복지재단 세포 원심분리 및 농축을 이용한 면역세포 검출 방법 및 면역세포 검출용 칩

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003025566A2 (en) 2001-09-17 2003-03-27 Imumed S.R.O. A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
WO2012105541A1 (ja) * 2011-01-31 2012-08-09 大鵬薬品工業株式会社 新規ヒノキ花粉アレルゲン

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132491A1 (de) 1980-08-22 1982-07-01 Laboratorium Prof. Dr. Rudolf Berthold, 7547 Wildbad Verfahren zur durchfuehrung analytischer bestimmungen mittels der chemilumineszenzmethode und anwendung des verfahrens fuer immunassays
US4902613A (en) 1984-05-14 1990-02-20 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
DE3587636T2 (de) 1984-05-31 1994-03-10 Coulter Corp Reagenssystem und verfahren zum nachweis, aufzählen und prüfen der klassen und unterklassen von blutleukozyten.
US6835551B2 (en) 1997-01-20 2004-12-28 Orpegen Pharma Gmbh Basophil degranulation test
FR2778413B1 (fr) 1998-05-07 2000-08-04 Immunotech Sa Nouveaux reactifs et methode de lyse des erythrocytes
DE10235310B4 (de) 2002-08-01 2012-05-16 Molecular And Clinical Drug Research Verfahren zur Bestimmung allergener Potenz von Produkten
RU2289138C2 (ru) * 2004-12-14 2006-12-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Способ аллергодиагностики по показателям хемилюминесцентного свечения нейтрофилов
EP2037269B1 (en) * 2007-09-11 2014-04-02 Bühlmann Laboratories AG Allergy test based on flow cytometric analysis
JP2009236798A (ja) 2008-03-28 2009-10-15 Sysmex Corp 好塩基球の分類計数方法
US20100167317A1 (en) * 2008-08-05 2010-07-01 Institut Pasteur Process for enriching basophils in a blood sample
WO2012028167A2 (en) 2010-05-20 2012-03-08 Innohyphen Bv Acridinium ester chemiluminescence upon reductive triggering
US20120083007A1 (en) 2010-10-01 2012-04-05 Nadeau Kari C Basophil Activation Based Allergy Diagnostic Test
WO2014066271A1 (en) * 2012-10-22 2014-05-01 Becton, Dickinson And Company Non-b-lineage cells capable of producing antibody
PL3051928T3 (pl) 2015-01-29 2019-07-31 Kjellberg-Stiftung Palnik plazmowy
CN104677810B (zh) * 2015-01-30 2017-08-22 广东医学院附属医院 嗜碱性粒细胞活化的检测试剂盒及其使用方法
CN104777303B (zh) * 2015-04-29 2017-02-01 何韶衡 一种嗜碱性粒细胞激活、脱颗粒的鉴定方法
EP3196209B1 (en) 2016-01-25 2019-10-23 Euroimmun Medizinische Labordiagnostika AG A macadamia allergen
EP3244212A1 (en) 2017-02-15 2017-11-15 Euroimmun Medizinische Labordiagnostika AG An improved assay for the diagnosis of peanut allergy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003025566A2 (en) 2001-09-17 2003-03-27 Imumed S.R.O. A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
JP2005509845A (ja) 2001-09-17 2005-04-14 イムメド エス．アール．オー． ある物質に対する過敏症を判定するための、アレルゲンによって誘起された好塩基球の賦活化の測定のための方法およびキット
WO2012105541A1 (ja) * 2011-01-31 2012-08-09 大鵬薬品工業株式会社 新規ヒノキ花粉アレルゲン

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Blank Simon et al, Journal of Immunology (2010.03.), vol 184(9), pp 5403-5413.
T Saarne et al, Clin Exp Allergy (2005.), vol 35(3), pp 657-663.

Also Published As

Publication number Publication date
AU2018213977A1 (en) 2019-02-28
AU2018213977B2 (en) 2025-02-20
CA3012989C (en) 2026-02-10
US20190049461A1 (en) 2019-02-14
BR102018015288A2 (pt) 2021-11-09
DE102018006212A1 (de) 2019-02-14
CA3012989A1 (en) 2019-02-08
JP2019032317A (ja) 2019-02-28
LT3441765T (lt) 2022-01-10
KR20190016446A (ko) 2019-02-18
EP3441765A1 (de) 2019-02-13
US11119109B2 (en) 2021-09-14
EP3441765B1 (de) 2021-10-20
CN109387636A (zh) 2019-02-26
SG10201806697RA (en) 2019-03-28
PL3441765T3 (pl) 2022-02-14
JP7265325B2 (ja) 2023-04-26
ES2904354T3 (es) 2022-04-04
CN109387636B (zh) 2023-07-04

Similar Documents

Publication Publication Date Title
EP2037269B1 (en) Allergy test based on flow cytometric analysis
CN102144161B (zh) 泛激酶活化与信号通路的评估
KR102547565B1 (ko) 호염기구 활성화 검사 방법
JP2012168012A (ja) 血管内皮障害を検査するための新規な検査方法および検査用キット
US20230349890A1 (en) Method for determination of basophil activation and kits therefore
JP4272431B2 (ja) 診断試験法
KR20020021774A (ko) 전염성 해면체성 뇌병증 진단 방법
US20110269162A1 (en) Ubiquitin proteasome system profiling for diagnosis of chronic liver disease
EP3788060A1 (en) Complement c4d assay
JP4242499B2 (ja) ホスホリルコリンを用いたｃｒｐの測定方法
US20160041185A1 (en) Methods of Detecting Complement Fixing and Non-Complement Fixing Antibodies and Systems for Practicing the Same
WO2003025566A2 (en) A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
CN115980369B (zh) 一种基于炎症反应分型的过敏原筛查试剂盒及其应用
TING et al. Urinary tubular biomarkers as potential early predictors of renal allograft rejection
EP3441763A1 (de) Verfahren zum nachweis einer basophilenaktivierung
Masilamani et al. Basophil degranulation assay
US20030022250A1 (en) Functional IgE test methods and compositions
US20130084584A1 (en) Method to detect tissue degradation leading to inflammation
TW202238131A (zh) 測量無細胞核蛋白染色質片段之方法
Alzahrani Assessing basophil activation in allergic disease by the measurement of the unique marker basogranulin: Release into cell supernatants and biological fluids, and alterations in intracellular and membrane expression
WO2011069009A1 (en) Polyubiquitin levels as a prognostic indicator in leukemia

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20180806

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210805

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20180806

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221114

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230530

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230621

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230622

End annual number: 3

Start annual number: 1

PG1601 Publication of registration